Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
33.01%
0%
33.01%
6 Months
0.09%
0%
0.09%
1 Year
-18.44%
0%
-18.44%
2 Years
-71.89%
0%
-71.89%
3 Years
-86.96%
0%
-86.96%
4 Years
-89.89%
0%
-89.89%
5 Years
-78.69%
0%
-78.69%
SHL Telemedicine Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-6.63%
EBIT Growth (5y)
-22.72%
EBIT to Interest (avg)
-0.07
Debt to EBITDA (avg)
0.58
Net Debt to Equity (avg)
-0.13
Sales to Capital Employed (avg)
0.75
Tax Ratio
49.74%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
2.47%
ROE (avg)
2.34%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
0.64
EV to EBIT
9.65
EV to EBITDA
3.69
EV to Capital Employed
0.63
EV to Sales
0.49
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
6.54%
ROE (Latest)
4.31%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot : Jun 2015
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.01%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'15 - YoY
Jun'15
Jun'14
Change(%)
Net Sales
10.90
9.10
19.78%
Operating Profit (PBDIT) excl Other Income
1.10
1.30
-15.38%
Interest
0.80
0.30
166.67%
Exceptional Items
-0.10
0.00
Consolidate Net Profit
-1.20
0.10
-1,300.00%
Operating Profit Margin (Excl OI)
-39.00%
6.80%
-4.58%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2015 is 19.78% vs 30.00% in Jun 2014
Consolidated Net Profit
YoY Growth in quarter ended Jun 2015 is -1,300.00% vs 0.00% in Jun 2014
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
50.00
51.30
-2.53%
Operating Profit (PBDIT) excl Other Income
0.40
0.80
-50.00%
Interest
1.20
1.40
-14.29%
Exceptional Items
-16.10
0.40
-4,125.00%
Consolidate Net Profit
-24.40
-6.20
-293.55%
Operating Profit Margin (Excl OI)
-124.40%
-119.30%
-0.51%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -2.53% vs -8.88% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -293.55% vs -3,200.00% in Dec 2023
About SHL Telemedicine Ltd. 
SHL Telemedicine Ltd.
Pharmaceuticals & Biotechnology
SHL Telemedicine Ltd (SHL) is an Israel-based company engaged in developing and marketing personal telemedicine solutions, with a focus on cardiovascular and related diseases. Personal telemedicine is the transmission of medical data by an individual, from a remote location, to a medical call center through telecommunication networks. SHL’s platform offers solutions to subscribing patients, health insurance companies, hospitals, clinics, physicians and other health care providers. Its solutions for healthcare professionals include: CHF monitoring service that supports patients suffering from Congestive Heart Failure; COPD monitoring service that supports patients suffering from Chronic Obstructive Pulmonary Disease, and Readmission Solutions for reducing heart-related readmissions. Its consumers' solutions include Cardiac Monitoring Service.
Company Coordinates 
Company Details
90 Yigal Alon St. , TEL AVIV-YAFO None : 67891
Registrar Details






